Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

METHYLTHIONINIUM CHLORIDE CRS(130 MG)

METHYLTHIONINIUM CHLORIDE CRS(130 MG)

61-73-4

DISCOVER
METIXENE HYDROCHLORIDE CRS (75 MG)

METIXENE HYDROCHLORIDE CRS (75 MG)

7081-40-5

DISCOVER
METOCLOPRAMIDE CRS (100 MG)

METOCLOPRAMIDE CRS (100 MG)

364-62-5

DISCOVER
METOCLOPRAMIDE IMPURITY A CRS(25 MG)

METOCLOPRAMIDE IMPURITY A CRS(25 MG)

NA

DISCOVER
METOCLOPRAMIDE HYDROCHLORIDE CRS (50 MG)

METOCLOPRAMIDE HYDROCHLORIDE CRS (50 MG)

54143-57-6

DISCOVER
METOCLOPRAMIDE IMPURITY E CRS(40 MG)

METOCLOPRAMIDE IMPURITY E CRS(40 MG)

100-36-7

DISCOVER
METOPROLOL TARTRATE CRS (60 MG)

METOPROLOL TARTRATE CRS (60 MG)

56392-17-7

DISCOVER
Metrifonate CRS, 100mg

Metrifonate CRS, 100mg

52-68-6

DISCOVER
METRONIDAZOLE CRS (20 MG)

METRONIDAZOLE CRS (20 MG)

443-48-1

DISCOVER
METRONIDAZOLE BENZOATE CRS (50 MG)

METRONIDAZOLE BENZOATE CRS (50 MG)

13182-89-3

DISCOVER
MEXILETINE HYDROCHLORIDE CRS (100 MG)

MEXILETINE HYDROCHLORIDE CRS (100 MG)

04/01/5370

DISCOVER
MIANSERIN HYDROCHLORIDE CRS (100 MG)

MIANSERIN HYDROCHLORIDE CRS (100 MG)

21535-47-7

DISCOVER